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Abstract.
The 4A11 antigen is a unique cytokine-inducible antigen upregulated on rheumatoid arthritis (RA) synovial endothelium compared to normal endothelium. In soluble form, , and is selectively expressed in skin, lymphoid organs, thymus, and synovium, suggesting that it may be important in leukocyte homing or adhesion. In the present study, we used H-2g as a functional substitute to demonstrate a novel property for Upregulation of ICAM-1 has been shown in joints and serum of RA patients (6, 7) . We have demonstrated previously that ICAM-1 expression on RA ST ECs is significantly higher compared with normal synovial ECs, suggesting that ICAM-1 promotes leukocyte adhesion and invasion into the RA joint (8, 9) .
Janus kinase-signal transducers and activators of transcription (JAK-STAT) signaling pathways have been reported to be involved in many signaling events such as the immune response induced cytokines, and in the actions of growth factors and hormones (10) . Specific subtypes of JAK (JAK1, JAK2, JAK3, and Tyk2) are activated by different signals, directing the specificity of response (11) . Immunoprecipitation and Western blotting -Quiescent HMEC-1 cells were treated with 100 nM H-2g, in the presence and absence of AG-490, for the specified time at 37°C. An IL-4 (10 ng/ml)/TNF-α (1.15 nM) combination was use as the positive control.
Alternatively, glycolipids Le y -6 (100 nM) or H-5-2 (100 nM) were used as stimulants.
The cells were then lysed in a buffer containing 20 nM HEPES, pH 7.4, 2 nM EDTA, 1 nM β-dithiothreitol, 50 nM glycerophosphate, 1% Triton X-100, 20 µg/ml aprotinin, 1 µg/ml leupeptin, 1 nM sodium orthovanadate, and 400 µM phenylmethylsulfonyl fluoride (PMSF). For immunoprecipitation, cell lysates containing equal amounts of protein were incubated with appropriate antibodies at 4°C for 2 hours. The antibody-protein complexes were incubated with protein A-sepharose CL-4B/protein A/G plus agarose beads overnight at 4°C, and antibody-protein complexes bound to the beads were pelleted at 2,000× g for 2 min. The beads were washed three times with lysis buffer and once with phosphate-buffered saline and resuspended in Laemmli sample buffer. The samples were resolved on 10% SDS-polyacrylamide gels. Western blots were performed as described previously (14) . The cells was scraped into 1.5 ml Eppendorf tubes and spun at 14,000 rpm at room temperature for 1 min to remove cell debris. Forty µl cell extract was added to the wells, and 50 µl substrate A and 50 µl substrate B added to the plate, and the luciferase activities were measured in a luminometer. GFP expression was measured by fluorescence-activated cell sorting (FACS) and efficiency was calculated by the percentage of positive expression.
Preparation of cytoplasmic and nuclear extracts for Western blotting -Quiescent
HMEC-1 cells treated with 100 nM H-2g for 5, 10 and 30 minutes were scraped off the plate, washed with PBS twice at 4°C, resuspended in 200 µl buffer A (10 mM Hepes pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, and 0.5 mM DTT, 1.5 µg/ml leupeptin, 20 mM benzamidine, 1.5 µg/ml pepstatin, 10 µg/ml aprotinin and 0.5 mM PMSF), and put on ice for 10 min. Two µl of 20% NP40 was added, the mixture was vortexed for 10 seconds, pelleted for 30 seconds, the supernatant (cytoplasmic extract) collected and stored at -70°C for Western blotting. The nuclear extracts were resuspended in 50 µl of buffer C (20 mM Hepes, pH7.9, 1.5 mM MgCl 2 , 420 mM NaCl, and 0.5 mM DTT, 25% glycerol, 0.2 mM EDTA, 1.5 µg/ml leupeptin, 20 mM benzamidine, 1.5 µg/ml pepstatin, 10 µg/ml aprotinin and 0.5 mM PMSF), rocked for 15 min in 4°C, and pelleted at 14,000 rpm for 5 min. The supernatants containing the nuclear extract were stored at -70°C for Western blotting.
Immunofluorescence assay -HMEC-1 cells were seeded on sterile slide coverslips in 6 Labeled HL-60 cells (2.5×10 5 /100 µl) were added to each well. Cells were incubated for one hour at 37°C and then were washed very carefully four times with pre-warmed PBS.
Fluorescence was determined using a fluorescent plate reader (SpectraMAX Gemini, Molecular Devices, Sunnyvale, CA) set to 495 nm for excitation and 517 nm for ICAM-1, VCAM-1, P-selectin, E-selectin, or isotype mouse-matched control (2.5 µg/ml) for 1 hr at 37°C and 5% CO 2 . HL-60 cells were labeled with calcAM and added to the HMEC-1 cells as described above (14) . 1000 nM H-2g. We found that H-2g-induced ICAM-1 expression in a concentration dependent manner, beginning at 10 nM (Fig.1A ). The peak time of H-2g-induced HMVEC ICAM-1 expression was 6 hours. In contrast, VCAM-1, E-selectin and Pselectin were not induced (Fig. 1B) . PBS was used as a negative control and 1.15 nM TNF-α was used as a positive control. We employed the Erk1/2 inhibitor (PD98059), the PI3K inhibitor (LY294002), the Src inhibitor (PP2) and the JAK2 inhibitor (AG-490) before (6 hours) and during the experiment, and found that the Erk1/2 inhibitor, the PI3K
inhibitor and the JAK inhibitor blocked ICAM-1 expression induced by H-2g. AG-490 had the most dramatic effect among these three inhibitors, and completely inhibited HMVEC ICAM-1 expression induced by H-2g, suggesting that JAK2 was a key signaling intermediate (Fig. 1C) . minutes. (Fig. 3B) . To confirm this result, we employed an immunofluorescence assay.
H-2g stimulates
We labeled the H-2g stimulated or non-stimulated HMEC-1s with anti-phospho-STAT3 
Phospho-JAK2 kinase is upstream of the Erk1/2 and PI3K-Akt pathways -JAK2 has
been suggested to be upstream of the MAPK and PI3K-Akt cascades (12, 18, 19) , and our data showed that inhibitors of Erk1/2 and PI3K-Akt partially block HMVEC ICAM-1 expression. To examine whether JAK2, Erk1/2 and PI3K-Akt were three independent pathways for H-2g signaling or whether they were contingent on one another, we performed Western blots to define these three pathways. Phosphorylated proteins were measured in Western blots using phospho-specific antibodies. H-2g activated Erk1/2 with peak expression at 5 min. We detected phospho-Akt after H-2g stimulation and found Akt was activated in the same manner as Erk1/2 (Fig. 4A) . We examined whether phospho-Erk1/2 and phospho-Akt induced by H-2g were JAK2 related. AG-490 (50 µM)
markedly inhibited H-2g-induced activation of Erk1/2 and Akt in Western blots.
However, no detectable change was observed in the steady-state Erk1/2 and Akt protein levels following treatment with H-2g, either in the presence or absence of AG-490, Following stimulation with H-2g (100 nM) for 6 hours, the adhesion index was increased 1.7 fold as compared with nonstimulated HMEC-1s. HL-60 cell adhesion to HMEC-1s
H-2g induces the adhesion of HL-60 cells to HMEC-1s
was induced by as little as 10 nM H-2g (Fig. 5A ). We found that this effect completely declined after 24 hour stimulation with 100 nM H-2g. Interestingly, we observed similar kinetics when HMEC-1s were stimulated with 1.15 nM TNF-α (Fig. 5B) . The JAK2 inhibitor (AG-490), the Erk1/2 inhibitor (PD98059), or the PI3K inhibitor (LY294002)
inhibited HL-60 cell adhesion to HMEC-1s ( Fig 5C) . Antibody to ICAM-1, but not to VCAM-1, E-selectin or P-selectin inhibited H-2g (100 nM) induced HL-60 cell adhesion to HMEC-1s thoroughly, which implies that H-2g-induced HL-60-HMEC-1 adhesion is mediated by ICAM-1 (Fig. 5D ).
Antisense ODNs of Erk1/2 and PI3K block HMVEC ICAM-1 expression and HL-60 cell
adhesion to HMEC-1s -We used inhibitors to the signaling proteins JAK2, Erk1/2 and PI3K to define their pathways. However, these inhibitors may not be completely specific.
To confirm the involvement of these pathways in H-2g signaling, antisense ODNs targeting JAK2, Erk1/2, PI3K and corresponding control sense ODNs were used to lipofectAMINE transfect HMEC-1s, with subsequent H-2g (100 nM) stimulation. Levels of pan-JAK2/phospho-JAK2, pan-Erk1/2/phospho-Erk1/2 and pan-Akt/phospho-Akt expression were determined by Western blots of total cell lysates. All of the pan-JAK2/phospho-JAK2, Erk1/2/phospho-Erk1/2 and pan-Akt/phospho-Akt expression was blocked by transfection of antisense ODNs to JAK2, Erk1/2 or PI3K (Fig. 6A) .
Furthermore, we examined ICAM-1 expression and HL-60 adhesion after ODN transfection. ICAM-1 expression was inhibited by antisense ODNs directed against JAK2, PI3K and Erk1/2 (Fig. 6B) . Consistent with the inhibition of ICAM-1 expression, JAK2, Erk1/2 and PI3K antisense ODNs inhibited HL-60 cell adhesion to HMEC-1s (Fig. 6C ).
Discussion.
The finding that the human genome encodes no more than 30,000-50,000 proteins (Fig. 7) . As shown in Fig. 7 , the JAK2 antisense ODN did not completely inhibit HMVEC ICAM-1 expression induced by H-2g. Because that the ODN is more specific, we suggest that other pathways, such as G-protein coupled receptors, may be involved in H-2g signaling.
ICAM-1 is expressed in human ECs, monocytes and lymphocytes, and mediates leukocyte binding to ECs (24) (25) (26) . It is broadly expressed in synovium from RA patients Phosphorylated STAT3 is released from the receptor complex and form dimers. Phospho-STAT3 dimers translocate to the nucleus where they directly bind to the promoter region of specific target genes, e.g. the ICAM-1 gene, thus regulating transcription of ICAM-1, which is involved in cell adhesion. Erk1/2 and PI3K-Akt are two parallel pathways which may be involved to lesser extent. Erk1/2 and PI3K may act directly on the transcription factor in the nucleus or through STAT3 dimers.
